首页> 美国卫生研究院文献>Contrast Media Molecular Imaging >In Vivo Quantification of Myocardial Infarction in Mice Using Micro-CT and a Novel Blood Pool Agent
【2h】

In Vivo Quantification of Myocardial Infarction in Mice Using Micro-CT and a Novel Blood Pool Agent

机译:使用Micro-CT和新型血池剂对小鼠心肌梗死进行体内定量

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

We herein developed a micro-CT method using the innovative contrast agent ExiTron™ MyoC 8000 to longitudinally monitor cardiac processes in vivo in small animals. Experiments were performed on healthy mice and mice with myocardial infarction inflicted by ligation of the left anterior descending artery. Time-dependent signal enhancement in different tissues of healthy mice was measured and various contrast agent doses were investigated so as to determine the minimum required dose for imaging of the myocardium. Due to its ability to be taken up by healthy myocardium but not by infarct tissue, ExiTron MyoC 8000 enables detection of myocardial infarction even at a very low dose. The signal enhancement in the myocardium of infarcted mice after contrast agent injection was exploited for quantification of infarct size. The values of infarct size obtained from the imaging method were compared with those obtained from histology and showed a significant correlation (R2 = 0.98). Thus, the developed micro-CT method allows for monitoring of a variety of processes such as cardiac remodeling in longitudinal studies.
机译:我们在这里开发了一种使用创新造影剂ExiTron™MyoC 8000的微型CT方法,以纵向监测小动物体内的心脏过程。实验在健康小鼠和结扎左前降支动脉引起的心肌梗塞小鼠中进行。测量了健康小鼠不同组织中随时间变化的信号增强,并研究了各种造影剂剂量,以确定心肌成像所需的最低剂量。由于ExiTron MyoC 8000可以被健康的心肌吸收,但不能被梗塞组织吸收,因此即使在非常低的剂量下也可以检测到心肌梗塞。造影剂注射后,在梗塞小鼠心肌中的信号增强被用于定量梗塞大小。将通过成像方法获得的梗死面积值与通过组织学获得的梗死面积值进行比较,并显示出显着的相关性(R 2 = 0.98)。因此,开发的微CT方法可用于监测多种过程,例如纵向研究中的心脏重塑。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号